The Dental Hemostat segmentation by Application reveals critical market dynamics driven by clinical use cases. Surgical procedures dominate, accounting for 65% of the market, as hemostats are essential for controlling bleeding during complex interventions like extractions, implants, and periodontal surgeries. This segment benefits from rising demand for advanced dental treatments and aging populations requiring corrective procedures. Conversely, non-surgical applications (35%), such as minor hemostasis during cavity treatments or orthodontic adjustments, represent a growing niche, fueled by preventive care trends and outpatient dental services. The surgical segmentโs higher revenue share underscores its role as the primary growth driver, while non-surgical applications highlight the productโs versatility in cost-sensitive, routine clinical settings. Together, they shape the market taxonomy by reflecting procedural complexity and regional healthcare spending patterns.